Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques
- PMID: 11710817
- PMCID: PMC2375164
- DOI: 10.1054/bjoc.2001.2077
Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques
Abstract
Antiangiogenic and antivascular agents provide new approaches to treating tumours. These may avoid many of the problems experienced with current approaches such as inherent and acquired resistance to treatment. Tumours do not grow beyond 1-2 mm(3) in size without the development of new vessels (Folkman, 1971). Such neo-vascularization (angiogenesis) allows tumour cells to increase their nutrient supply, survive and proliferate despite the new vessels often having structural and functional differences compared to normal tissue vasculature. Treatments targeted at tumour vasculature have produced impressive results in animal models (Lindsay et al, 1996; Watson et al, 1996; O'Reilly, 1997; Horsman et al, 1998). These therapies are now entering clinical trials. However, the successful introduction of these therapies into clinical practice will require the development of reliable ways to assess angiogenesis and its modification or inhibition in vivo. Here we discuss some of the emerging imaging techniques that may be useful.
Copyright 2001 Cancer Research Campaign http://www.bjcancer.com.
Similar articles
-
Imaging vascular physiology to monitor cancer treatment.Crit Rev Oncol Hematol. 2006 May;58(2):95-113. doi: 10.1016/j.critrevonc.2005.10.006. Epub 2006 Jan 4. Crit Rev Oncol Hematol. 2006. PMID: 16387510 Review.
-
Measuring tumour vascular response to antivascular and antiangiogenic drugs.Br J Radiol. 2003;76 Spec No 1:S23-35. doi: 10.1259/bjr/30165281. Br J Radiol. 2003. PMID: 15456711 Review.
-
3-D Longitudinal Imaging of Tumor Angiogenesis in Mice in Vivo Using Ultrafast Doppler Tomography.Ultrasound Med Biol. 2019 May;45(5):1284-1296. doi: 10.1016/j.ultrasmedbio.2018.12.010. Epub 2019 Feb 22. Ultrasound Med Biol. 2019. PMID: 30799125
-
The use of vascular biomarkers and imaging studies in the early clinical development of anti-tumour agents targeting angiogenesis.J Intern Med. 2006 Dec;260(6):517-29. doi: 10.1111/j.1365-2796.2006.01727.x. J Intern Med. 2006. PMID: 17116002 Review.
-
Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy.Br J Radiol. 1993 Mar;66(783):181-96. doi: 10.1259/0007-1285-66-783-181. Br J Radiol. 1993. PMID: 7682469 Review.
Cited by
-
Evaluation of tumor angiogenesis with a second-generation US contrast medium in a rat breast tumor model.Korean J Radiol. 2008 May-Jun;9(3):243-9. doi: 10.3348/kjr.2008.9.3.243. Korean J Radiol. 2008. PMID: 18525227 Free PMC article.
-
Portable, handheld, and affordable blood perfusion imager for screening of subsurface cancer in resource-limited settings.Proc Natl Acad Sci U S A. 2022 Jan 11;119(2):e2026201119. doi: 10.1073/pnas.2026201119. Proc Natl Acad Sci U S A. 2022. PMID: 34983869 Free PMC article.
-
Current Concepts in Multi-Modality Imaging of Solid Tumor Angiogenesis.Cancers (Basel). 2020 Nov 3;12(11):3239. doi: 10.3390/cancers12113239. Cancers (Basel). 2020. PMID: 33153067 Free PMC article. Review.
-
Correlation of contrast-enhanced ultrasound kinetics with prognostic factors in invasive breast cancer.Eur Radiol. 2013 Dec;23(12):3228-36. doi: 10.1007/s00330-013-2960-5. Epub 2013 Jul 3. Eur Radiol. 2013. PMID: 23821023
-
Use of Radioiodinated Peptide Arg-Arg-Leu Targeted to Neovasculari- zation as well as Tumor Cells in Molecular Tumor Imaging.Chin J Cancer Res. 2012 Mar;24(1):52-9. doi: 10.1007/s11670-012-0052-8. Chin J Cancer Res. 2012. PMID: 23359762 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
